Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.

Abstract

The introduction of cyclosporine A (CsA) and FK506 significantly improved the outcome of liver transplantation. However, the postoperative course and outcome of liver transplant recipients in still compromised by rejection, over-immunosuppression-induced infection and immunosuppression-associated toxicity. In the present study, we evaluated the reason for… (More)

Topics

Cite this paper

@article{Platz1995ToxicityVR, title={Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.}, author={Kenneth Platz and Andrea M{\"u}ller and Stephan Jonas and Gerhard Blumhardt and W. O. Bechstein and H. Hartmut Lobeck and Henner Neuhaus}, journal={Clinical transplantation}, year={1995}, volume={9 3 Pt 1}, pages={146-54} }